Cognitive decline can range from mild memory issues to severe dementia, with Alzheimer’s disease being the most common form.

Professor Seán Kennelly from the Tallaght Institute of Memory and Cognition believes this study is a major step forward in ...

Biogen’s disappointing Leqembi performance and weak pipeline hurt future growth. Learn why BIIB stock is rated "sell" due to ...

US FDA grants fast track designation to NKGen Biotech’s natural killer cell therapy, troculeucel to treat moderate Alzheimer’s disease: Santa Ana, California Saturday, Februar ...

A 5-year-old killed in a hyperbaric chamber fire last month in Michigan was receiving treatment for sleep apnea and ADHD, ...

US researchers behind the new analysis said they hoped the findings would help patients weigh up the potential benefits of ...

Up to half of all people living with Alzheimer's Disease in Ireland remain undiagnosed. Now, a new blood test may have the ...

Alzheimer's disease, a type of dementia that profoundly alters a person’s memory and cognitive function, affects an estimated ...

Progressive and incurable, Alzheimer’s disease affects an estimated 6.7 million U.S. adults at least 65 years old, according ...

Scientists have identified a biomarker for Alzheimer's that may help doctors spot the early signs of protein buildup in the ...

Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,” Charles Piller looks how the amyloid hypothesis took over ...

Dr Joyce Huang will be joined by Dr Emma Mead to discuss the ways we’re widening the search for new dementia treatments.